Tyra Biosciences, Inc.
TYRA나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
0건
최근 2026.09.21
90일 내부자 순매수
+2,800만원
순매수
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 10건
- US미국대량보유(5%)중요도 보통2026.09.21SCHEDULE 13G · Beneficial ownership report (13G)
Tyra Biosciences, Inc.TYRA
SCHEDULE 13G · 2026.09.21
- US미국임원·주요주주 소유중요도 낮음2026.09.174 · Statement of changes in beneficial ownership
Tyra Biosciences, Inc.TYRA
Form 4 · 2026.09.17
- US미국대량보유(5%)중요도 보통2026.09.17SCHEDULE 13G · Beneficial ownership report (13G)
Tyra Biosciences, Inc.TYRA
SCHEDULE 13G · 2026.09.17
- US미국임원·주요주주 소유중요도 낮음2026.09.174 · Statement of changes in beneficial ownership
Tyra Biosciences, Inc.TYRA
Form 4 · 2026.09.17
- US미국대량보유(5%)중요도 보통2026.09.17정정SCHEDULE 13D/A · Beneficial ownership report (13D)
Tyra Biosciences, Inc.TYRA
SCHEDULE 13D/A · 2026.09.17
- US미국임원·주요주주 소유중요도 높음2026.09.174 · Statement of changes in beneficial ownership
Tyra Biosciences, Inc.TYRA
Form 4 · 2026.09.17
- US미국임원·주요주주 소유중요도 낮음2026.09.174 · Statement of changes in beneficial ownership
Tyra Biosciences, Inc.TYRA
Form 4 · 2026.09.17
- US미국주요사항·수시공시중요도 낮음2026.09.158-K · Current report (Items 8.01, 9.01)
Tyra Biosciences, Inc.TYRA
8-K · 2026.09.15 08:12 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.114 · Statement of changes in beneficial ownership
Tyra Biosciences, Inc.TYRA
Form 4 · 2026.09.11
- US미국주요사항·수시공시중요도 낮음2026.09.098-K · Current report (Items 8.01)
Tyra Biosciences, Inc.TYRA
8-K · 2026.09.09 20:10 KST